======= LAIR1 ======= == Gene Information == * **Official Symbol**: LAIR1 * **Official Name**: leukocyte associated immunoglobulin like receptor 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3903|3903]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q6GTX8|Q6GTX8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LAIR1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LAIR1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602992|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Functions as an inhibitory receptor that plays a constitutive negative regulatory role on cytolytic function of natural killer (NK) cells, B-cells and T-cells. Activation by Tyr phosphorylation results in recruitment and activation of the phosphatases PTPN6 and PTPN11. It also reduces the increase of intracellular calcium evoked by B-cell receptor ligation. May also play its inhibitory role independently of SH2-containing phosphatases. Modulates cytokine production in CD4+ T-cells, down- regulating IL2 and IFNG production while inducing secretion of transforming growth factor beta. Down-regulates also IgG and IgE production in B-cells as well as IL8, IL10 and TNF secretion. Inhibits proliferation and induces apoptosis in myeloid leukemia cell lines as well as prevents nuclear translocation of NF-kappa-B p65 subunit/RELA and phosphorylation of I-kappa-B alpha/CHUK in these cells. Inhibits the differentiation of peripheral blood precursors towards dendritic cells. {ECO:0000269|PubMed:10229813, ECO:0000269|PubMed:10764762, ECO:0000269|PubMed:11069054, ECO:0000269|PubMed:11160222, ECO:0000269|PubMed:12072189, ECO:0000269|PubMed:15939744, ECO:0000269|PubMed:15950745, ECO:0000269|PubMed:16380958, ECO:0000269|PubMed:9285412, ECO:0000269|PubMed:9692876}. No Pfam Domain information is available for this gene. |tertiary granule membrane| |specific granule membrane| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |myeloid leukocyte activation| |adaptive immune response| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulated exocytosis| |leukocyte mediated immunity| |exocytosis| |leukocyte activation| |secretion by cell| |export from cell| |cell activation| |immune effector process| |secretion| |regulation of immune response| |regulation of immune system process| |immune response| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp111|R-DABN 8μM R03 exp111]]|-1.9| ^Gene^Correlation^ |[[:human genes:r:ruvbl2|RUVBL2]]|0.483| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5322 * **Expression level (log2 read counts)**: 6.57 {{:chemogenomics:nalm6 dist.png?nolink |}}